Inhalation/intravenous recombinant tissue plasminogen activator and inhaled heparin in a patient with acute respiratory distress syndrome

Citation
J. Gram et al., Inhalation/intravenous recombinant tissue plasminogen activator and inhaled heparin in a patient with acute respiratory distress syndrome, FIBRINOL PR, 13(4-5), 1999, pp. 209-212
Citations number
24
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
FIBRINOLYSIS & PROTEOLYSIS
ISSN journal
13690191 → ACNP
Volume
13
Issue
4-5
Year of publication
1999
Pages
209 - 212
Database
ISI
SICI code
1369-0191(199907/09)13:4-5<209:IRTPAA>2.0.ZU;2-5
Abstract
Recent studies have demonstrated that lung fibrin deposits are associated w ith evolution of acute respiratory distress syndrome (ARDS). A young woman with ARDS resistant to conventional treatment was treated with ultrasonic n ebulized rt-PA (30 mg) and intravenous rt-PA (20 mg) over 2 h followed by c ontinuous treatment with ultrasonic nebulized unfractionated heparin (15 00 0 IU/day). The pulmonary gas exchange of the patient improved significantly and the condition of the patient stabilized during the hours following the fibrinolytic treatment. The potential use of nebulized thrombolytics for l ocal treatment of ARDS is discussed, and we conclude that combined nebulize d and intravenous therapy with thrombolytics may improve physiologic derang ements associated with acute lung injury in ARDS. (C) Harcourt Publishers L td 1999.